Furthermore, no studies to date have reported pharmacokinetic parameters (e.g., absorption, bioavailability, tissue distribution), nor have they conducted long-term toxicity assessments or evaluated reproductive outcomes in vivo
Research has found that many chronic diseases are associated with a reduction in glutathione levels, leading to the hypothesis that increasing glutathione levels can help prevent and/or mitigate the progression of these diseases
Injectable Peptide Therapy Trends
RESULTS Here, to evidence a link between inflammatory bowel disease and multiple sclerosis that may be useful in practice, BPC 157 was used per-orally in rats subjected to cysteamine enema + colon-colon anastomosis colitis (9-11) and over-dose cuprizone application, a multiple sclerosis suited toxic experimental model (12)
Cao HY, Lian JN, Lin ZS, Zhu ZW, Wang H,Wang HY